Gashaw Arega and Dr. Abel Hailu Announced the Official Establishment of the ESPHO
Gashaw Arega, Pediatric-Hematologist and Oncologist at Addis Ababa University, reposted Dr. Abel Hailu’s post on LinkedIn:
“Proud to be part of and witness this historic moment — the official establishment of the Ethiopian Society of Pediatric Hematology and Oncology (ESPHO).
As a founding and Executive Committee member of ESPHO, I am truly honored to join this dedicated team committed to transforming childhood cancer and hematologic care across our country.
Great job, Ethiopian ESPHO colleagues and friends!”
Quoting Dr. Abel Hailu’s post:
“It is with profound honor and joy that I announce the official establishment of the Ethiopian Society of Pediatric Hematology and Oncology (ESPHO) — a collective vision brought to life by dedicated hemato-oncologists from across the nation.
I am deeply humbled to serve as the inaugural President of this remarkable Society. ESPHO is more than an organization; it is a movement — one that will leave an indelible mark on the landscape of pediatric cancer care in Ethiopia. Together, we will forge a future where every child has access to hope, healing, and the highest standards of care.”

Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial